HTBX
(NASDAQ)
0.8320
+0.0360  (+4.33%)
Volume (24h): 4.33M Day Range: 0.7925 - 0.8489
Market Cap: 70.44M 52W Range: 0.1950 - 1.25
Jun-01-20 10:15AM HTBX: The Antigen Chaperone: gp96Zacks Small Cap Research
May-29-20 12:00PM Heat Biologics Presents Positive Survival Benefit for HS-110 in Combination with Nivolumab in Phase 2 Lung Cancer Trial at 2020 American Society of Clinical Oncology (ASCO) Annual MeetingACCESSWIRE
May-28-20 03:34PM ER doctor: 12-18 month coronavirus vaccine timeline 'is extremely optimistic'Yahoo Finance
May-27-20 12:00PM Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 VaccineACCESSWIRE
May-18-20 11:45AM We're Keeping An Eye On Heat Biologics's (NASDAQ:HTBX) Cash Burn RateSimply Wall St.
May-15-20 01:30PM Heat Biologics Provides First Quarter 2020 Business UpdateACCESSWIRE
May-14-20 12:00PM Positive Survival Data from Phase 2 Lung Cancer Trial Accepted for Presentation at 2020 American Society of Clinical Oncology (ASCO) Annual MeetingACCESSWIRE
May-11-20 12:00PM Heat Biologics Provides Clinical Update; Reports Continued Progress Advancing HS-110ACCESSWIRE
Apr-29-20 12:37PM Heat Biologics Reports Progress on COVID-19 Efforts and Timeline of Anticipated Q2 2020 MilestonesACCESSWIRE
Apr-09-20 07:45PM HTBX: $25M in Cash to Advance PortfolioZacks Small Cap Research
Apr-05-20 02:23PM These 19 companies are working on coronavirus treatments or vaccines — here’s where things standMarketWatch
Apr-04-20 08:26PM These 19 companies are working on coronavirus treatments or vaccines — here’s where things standMarketWatch
Apr-01-20 12:00PM Heat Biologics Announces Formation of COVID-19 Advisory BoardACCESSWIRE
10:10AM These 19 companies are working on coronavirus treatments or vaccines — here’s where things standMarketWatch
Mar-31-20 06:13PM These 19 companies are working on coronavirus treatments or vaccines — here’s where things standMarketWatch
11:04AM These 16 companies are working on coronavirus treatments or vaccines — here’s where things standMarketWatch
Mar-30-20 04:29PM These 16 companies are working on coronavirus treatments or vaccines — here’s where things standMarketWatch
12:30PM Heat Biologics Provides Year-End Business UpdateACCESSWIRE
Mar-28-20 02:28PM These 16 companies are working on coronavirus treatments or vaccines — here’s where things standMarketWatch
Mar-24-20 11:25AM These 16 companies are working on coronavirus treatments or vaccines — here’s where things standMarketWatch
Mar-23-20 07:59PM These 16 companies are working on coronavirus treatments or vaccines — here’s where things standMarketWatch
06:38PM Morrisville firm developing coronavirus test that produces results in 30 minutesAmerican City Business Journals
Mar-23-20 01:00PM Heat Biologics and University of Miami Developing Proprietary COVID-19 Diagnostic Test Under Collaborative Research AgreementACCESSWIRE
Mar-22-20 02:18PM These 15 companies are working on coronavirus treatments or vaccines — here’s where things standMarketWatch
Mar-21-20 03:12PM These 15 companies are working on coronavirus treatments or vaccines — here’s where things standMarketWatch
Mar-18-20 07:32PM These 15 companies are working on coronavirus treatments or vaccines — here’s where things standMarketWatch
11:01AM These 13 companies are working on coronavirus treatments or vaccines — here’s where things standMarketWatch
Mar-17-20 07:03PM These 13 companies are working on coronavirus treatments or vaccines — here’s where things standMarketWatch
06:35PM Shares of Heat Biologics rise on plans to develop COVID-19 vaccine candidateMarketWatch
Mar-16-20 12:00PM Heat Biologics Invited to Join The Alliance for BiosecurityACCESSWIRE
Mar-11-20 01:23PM Biotech Maven Hal Mintz Snaps Up These 3 Small Biotech StocksTipRanks
Mar-09-20 02:55PM On the Back of Possible Coronavirus Vaccine, Analyst Sees Over 170% Upside for Heat BiologicsTipRanks
Mar-06-20 06:52PM TBJ Plus: Coronavirus threatens ACC Tournament, hurts Raleigh restaurants; Reynolds mansion still unsold; Peek inside this new breweryAmerican City Business Journals
Mar-05-20 09:45PM Heat Biologics, Inc. to Present at the Spring Investor Summit on March 25th-26th in New York CityACCESSWIRE
02:00PM Heat Biologics Announces Research Collaboration with University of Miami to Develop Vaccine Designed to Protect Against COVID-19 CoronavirusACCESSWIRE
Mar-04-20 08:10PM Heat Biologics CEO to Appear Today on ABC11-WTVD to Discuss the Company’s Newly Launched Program to Develop a Vaccine to Protect Against SARS-CoV-2 Coronavirus that Causes COVID-19ACCESSWIRE
02:48PM 3 Biotech Stocks Join the Coronavirus FightTipRanks
Mar-03-20 07:41PM Morrisville company joins race for coronavirus vaccineAmerican City Business Journals
01:00PM Benzinga Pro's Top 6 Stocks To Watch For Tues., Mar. 3, 2020: TGT, BYND, UBER, NOVN, QRVO, HTBXBenzinga
Mar-03-20 01:00PM Heat Biologics Launches Program to Develop Vaccine Designed to Protect Against COVID-19 CoronavirusACCESSWIRE
Feb-28-20 07:15PM SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Heat Biologics, Inc.- HTBXACCESSWIRE
Feb-24-20 07:59PM Advance Auto Parts, Cree among Triangle companies hit as stocks tumble with rising concern over coronavirusAmerican City Business Journals
Jan-21-20 09:05PM Heat Biologics, Inc. Announces Closing of $7,000,000 Public OfferingACCESSWIRE
Jan-16-20 02:50PM Heat Biologics, Inc. Prices $7,000,000 Public OfferingACCESSWIRE
Jan-15-20 07:33PM Triangle drugmaker preps for public offeringAmerican City Business Journals
Dec-23-19 01:39PM Here's What We Think About Heat Biologics, Inc.'s (NASDAQ:HTBX) CEO PaySimply Wall St.
Dec-16-19 12:00PM Heat Biologics Announces First Patient Dosed in the First Phase 1 Trial of HS-130ACCESSWIRE
Nov-29-19 10:05AM HTBX: Third Quarter 2019 ResultsZacks Small Cap Research
Nov-20-19 01:00PM Heat Biologics Announces Additional Positive Top Line Phase 2 Data of HS-110 plus Nivolumab in Advanced NSCLC PatientsACCESSWIRE
Nov-19-19 12:56PM The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy ReadoutBenzinga
Heat Biologics, Inc., a biopharmaceutical company, focuses on developing approaches to activate and co-stimulate a patient's immune system against cancer in the United States. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors hot and be administered in combination with checkpoint inhibitors and other immuno-modulators to enhance clinical effectiveness. Its TCAP product candidates include ImPACT platform technology that develops product candidates consist of live, allogeneic off-the-shelf genetically-modified, and irradiated human cancer cells; and Combination Pan-antigen Cytotoxic Therapy, a dual-acting immunotherapy designed to deliver T-cell activation and enhanced, and T-cell specific co-stimulation in a single treatment. The company is developing HS-110 that is in Phase 2 clinical trial in combination with Bristol-Myers Squibb's nivolumab (Opdivo) for the treatment of non-small cell lung cancer. Its preclinical trial product candidates include HS-130 for the treatment of non-muscle invasive bladder cancer; and PTX-35 and PTX-15 for treating tumors and hematologic malignancies. The company was founded in 2008 and is headquartered in Durham, North Carolina.
Stocks in other countries: United Kingdom India Canada Australia
Market Cap
Volume (24h)